{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T20:03:44Z","timestamp":1780085024186,"version":"3.54.0"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thrombosisresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.thromres.2020.12.006","type":"journal-article","created":{"date-parts":[[2020,12,16]],"date-time":"2020-12-16T17:28:25Z","timestamp":1608139705000},"page":"171-181","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Impact of uric acid on immature platelet fraction in patients undergoing percutaneous coronary intervention"],"prefix":"10.1016","volume":"198","author":[{"given":"Matteo","family":"Nardin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Verdoia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Negro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Tonon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"De Luca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.thromres.2020.12.006_bb0005","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.amjcard.2013.10.039","article-title":"Five-year follow-up of patients treated for coronary artery disease in the face of an increasing burden of co-morbidity and disease complexity (from the NHLBI Dynamic Registry)","volume":"113","author":"Bortnick","year":"2014","journal-title":"Am. J. Cardiol."},{"issue":"2","key":"10.1016\/j.thromres.2020.12.006_bb0010","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.thromres.2014.05.025","article-title":"Relationship between homocysteine and coronary artery disease. Results from a large prospective cohort study","volume":"134","author":"Schaffer","year":"2014","journal-title":"Thromb. Res."},{"issue":"5","key":"10.1016\/j.thromres.2020.12.006_bb0015","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.numecd.2015.01.009","article-title":"Impact of gender difference on vitamin D status and its relationship with the extent of coronary artery disease","volume":"25","author":"Verdoia","year":"2015","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"issue":"4","key":"10.1016\/j.thromres.2020.12.006_bb0020","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1007\/s11239-010-0531-z","article-title":"High fibrinogen level is an independent predictor of presence and extent of coronary artery disease among Italian population","volume":"31","author":"De Luca","year":"2011","journal-title":"J. Thromb. Thrombolysis"},{"issue":"11","key":"10.1016\/j.thromres.2020.12.006_bb0025","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1007\/s40265-015-0425-7","article-title":"Platelet GP IIb-IIIa receptor antagonists in primary angioplasty: Back to the future","volume":"75","author":"De Luca","year":"2015","journal-title":"Drugs."},{"issue":"5","key":"10.1016\/j.thromres.2020.12.006_bb0030","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1111\/ijlh.12049","article-title":"Establishment of reference interval for immature platelet fraction","volume":"35","author":"Ko","year":"2013","journal-title":"Int. J. Lab. Hematol."},{"issue":"2","key":"10.1016\/j.thromres.2020.12.006_bb0035","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/j.1600-0609.2010.01468.x","article-title":"Correlation between immature platelet fraction and reticulated platelets. Usefulness in the etiology diagnosis of thrombocytopenia","volume":"85","author":"Pons","year":"2010","journal-title":"Eur. J. Haematol."},{"issue":"5","key":"10.1016\/j.thromres.2020.12.006_bb0040","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1160\/TH12-09-0709","article-title":"Reticulated platelets predict cardiovascular death in acute coronary syndrome patients. Insights from the AMI-Florence 2 study","volume":"109","author":"Cesari","year":"2013","journal-title":"Thromb. Haemost."},{"issue":"10","key":"10.1016\/j.thromres.2020.12.006_bb0045","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1016\/j.jacc.2004.05.033","article-title":"Reticulated platelets in acute coronary syndrome: a marker of platelet activity","volume":"44","author":"Lakkis","year":"2004","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.thromres.2020.12.006_bb0050","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.atherosclerosis.2017.03.044","article-title":"Immature platelet fraction and the extent of coronary artery disease: a single centre study","volume":"260","author":"Verdoia","year":"2017","journal-title":"Atherosclerosis."},{"issue":"7","key":"10.1016\/j.thromres.2020.12.006_bb0055","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1002\/art.24612","article-title":"Hyperuricemia and risk of stroke: a systematic review and meta-analysis","volume":"61","author":"Kim","year":"2009","journal-title":"Arthritis Rheum."},{"issue":"1","key":"10.1016\/j.thromres.2020.12.006_bb0060","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.diabres.2013.03.026","article-title":"Serum uric acid levels and incidence of impaired fasting glucose and type 2 diabetes mellitus: a meta-analysis of cohort studies","volume":"101","author":"Jia","year":"2013","journal-title":"Diabetes Res. Clin. Pract."},{"issue":"12","key":"10.1016\/j.thromres.2020.12.006_bb0065","doi-asserted-by":"crossref","first-page":"e114259","DOI":"10.1371\/journal.pone.0114259","article-title":"Hyperuricemia and risk of incident hypertension: a systematic review and meta-analysis of observational studies. Remuzzi G, editor","volume":"9","author":"Wang","year":"2014","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.thromres.2020.12.006_bb0070","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.atherosclerosis.2013.08.023","article-title":"Baseline serum uric acid level as a predictor of cardiovascular disease related mortality and all-cause mortality: a meta-analysis of prospective studies","volume":"231","author":"Zhao","year":"2013","journal-title":"Atherosclerosis."},{"key":"10.1016\/j.thromres.2020.12.006_bb0075","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.atherosclerosis.2016.10.006","article-title":"Elevated serum uric acid and risk of cardiovascular or all-cause mortality in people with suspected or definite coronary artery disease: a meta-analysis","volume":"254","author":"Wang","year":"2016","journal-title":"Atherosclerosis."},{"issue":"11","key":"10.1016\/j.thromres.2020.12.006_bb0080","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1161\/01.RES.0000149571.96304.36","article-title":"Xanthine oxidoreductase is an endogenous regulator of cyclooxygenase-2","volume":"95","author":"Ohtsubo","year":"2004","journal-title":"Circ. Res."},{"issue":"Suppl. 1","key":"10.1016\/j.thromres.2020.12.006_bb0085","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1111\/j.1538-7836.2007.02498.x","article-title":"Resistance to antiplatelet drugs: molecular mechanisms and laboratory detection","volume":"5","author":"Cattaneo","year":"2007","journal-title":"J. Thromb. Haemost."},{"issue":"11","key":"10.1016\/j.thromres.2020.12.006_bb0090","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1016\/j.metabol.2013.07.001","article-title":"Maladaptive immune and inflammatory pathways lead to cardiovascular insulin resistance","volume":"62","author":"Aroor","year":"2013","journal-title":"Metabolism."},{"issue":"6","key":"10.1016\/j.thromres.2020.12.006_bb0095","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1161\/01.HYP.0000072820.07472.3B","article-title":"Uric acid stimulates monocyte chemoattractant Protein-1 production in vascular smooth muscle cells via mitogen-activated protein kinase and Cyclooxygenase-2","volume":"41","author":"Kanellis","year":"2003","journal-title":"Hypertension."},{"issue":"12","key":"10.1016\/j.thromres.2020.12.006_bb0100","doi-asserted-by":"crossref","first-page":"2888","DOI":"10.1097\/01.ASN.0000034910.58454.FD","article-title":"A role for uric acid in the progression of renal disease","volume":"13","author":"Kang","year":"2002","journal-title":"J. Am. Soc. Nephrol."},{"issue":"4 suppl 2","key":"10.1016\/j.thromres.2020.12.006_bb0105","doi-asserted-by":"crossref","first-page":"S69","DOI":"10.1681\/ASN.2005121331","article-title":"Serum uric acid: a risk factor and a target for treatment?","volume":"17","author":"Feig","year":"2006","journal-title":"J. Am. Soc. Nephrol."},{"issue":"2","key":"10.1016\/j.thromres.2020.12.006_bb0110","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s11239-016-1348-1","article-title":"Impact of diabetes on immature platelets fraction and its relationship with platelet reactivity in patients receiving dual antiplatelet therapy","volume":"42","author":"Verdoia","year":"2016","journal-title":"J. Thromb. Thrombolysis"},{"issue":"2","key":"10.1016\/j.thromres.2020.12.006_bb0115","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.amjcard.2010.08.063","article-title":"Meta-analysis of randomized trials of glycoprotein IIb\/IIIa inhibitors in high-risk acute coronary syndromes patients undergoing invasive strategy","volume":"107","author":"De Luca","year":"2011","journal-title":"Am. J. Cardiol."},{"issue":"8","key":"10.1016\/j.thromres.2020.12.006_bb0120","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.jcin.2014.02.016","article-title":"Randomized comparison of everolimus-eluting stents and sirolimus-eluting stents in patients with ST elevation myocardial infarction: RACES-MI trial","volume":"7","author":"Di Lorenzo","year":"2014","journal-title":"JACC Cardiovasc Interv."},{"issue":"3","key":"10.1016\/j.thromres.2020.12.006_bb0125","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1093\/qjmed\/hcq258","article-title":"Early vs. delayed invasive strategy in patients with acute coronary syndromes without ST-segment elevation: a meta-analysis of randomized studies","volume":"104","author":"Navarese","year":"2011","journal-title":"QJM."},{"issue":"3","key":"10.1016\/j.thromres.2020.12.006_bb0130","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1016\/j.ijcard.2013.01.161","article-title":"Comprehensive meta-analysis of radial vs femoral approach in primary angioplasty for STEMI","volume":"168","author":"De Luca","year":"2013","journal-title":"Int. J. Cardiol."},{"issue":"3","key":"10.1016\/j.thromres.2020.12.006_bb0135","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1177\/107602960300900301","article-title":"Platelets as predictors of vascular risk: is there a practical index of platelet activity?","volume":"9","author":"Tsiara","year":"2003","journal-title":"Clin. Appl. Thromb. Hemost."},{"issue":"6","key":"10.1016\/j.thromres.2020.12.006_bb0140","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1093\/ajcp\/98.6.637","article-title":"The significance of platelets with increased RNA content (reticulated platelets). A measure of the rate of thrombopoiesis","volume":"98","author":"Ault","year":"1992","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.thromres.2020.12.006_bb0145","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.cca.2014.10.024","article-title":"Clinical applicability of reticulated platelets","volume":"439","author":"Dusse","year":"2015","journal-title":"Clin. Chim. Acta"},{"issue":"1","key":"10.1016\/j.thromres.2020.12.006_bb0150","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1160\/TH08-03-0186","article-title":"Immature platelets in patients with acute coronary syndromes","volume":"101","author":"Grove","year":"2009","journal-title":"Thromb. Haemost."},{"issue":"45","key":"10.1016\/j.thromres.2020.12.006_bb0155","doi-asserted-by":"crossref","first-page":"3202","DOI":"10.1093\/eurheartj\/ehv326","article-title":"Impact of immature platelets on platelet response to ticagrelor and prasugrel in patients with acute coronary syndrome","volume":"36","author":"Bernlochner","year":"2015","journal-title":"Eur. Heart J."},{"issue":"6","key":"10.1016\/j.thromres.2020.12.006_bb0160","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.jacc.2013.07.110","article-title":"Response to prasugrel and levels of circulating reticulated platelets in patients with ST-segment elevation myocardial infarction","volume":"63","author":"Perl","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.thromres.2020.12.006_bb0165","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ijcard.2017.06.022","article-title":"Everolimus eluting stent vs first generation drug-eluting stent in primary angioplasty: a pooled patient-level meta-analysis of randomized trials","volume":"244","author":"De Luca","year":"2017","journal-title":"Int. J. Cardiol."},{"issue":"9","key":"10.1016\/j.thromres.2020.12.006_bb0170","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.jacc.2008.05.031","article-title":"Role of reticulated platelets and platelet size heterogeneity on platelet activity after dual antiplatelet therapy with aspirin and clopidogrel in patients with stable coronary artery disease","volume":"52","author":"Guthikonda","year":"2008","journal-title":"J. Am. Coll. Cardiol."},{"issue":"1","key":"10.1016\/j.thromres.2020.12.006_bb0175","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1007\/s11239-014-1156-4","article-title":"Circulating reticulated platelets over time in patients with myocardial infarction treated with prasugrel or ticagrelor","volume":"40","author":"Eisen","year":"2015","journal-title":"J. Thromb. Thrombolysis"},{"issue":"6","key":"10.1016\/j.thromres.2020.12.006_bb0180","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.thromres.2013.09.035","article-title":"Immature platelet fraction in diabetes mellitus and metabolic syndrome","volume":"132","author":"Lee","year":"2013","journal-title":"Thromb. Res."},{"issue":"1","key":"10.1016\/j.thromres.2020.12.006_bb0185","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1467-789X.2011.00930.x","article-title":"Platelet activation in obesity and metabolic syndrome","volume":"13","author":"Santilli","year":"2012","journal-title":"Obes. Rev."},{"issue":"1","key":"10.1016\/j.thromres.2020.12.006_bb0190","doi-asserted-by":"crossref","first-page":"7","DOI":"10.7326\/0003-4819-131-1-199907060-00003","article-title":"Serum uric acid and risk for cardiovascular disease and death: the Framingham Heart Study","volume":"131","author":"Culleton","year":"1999","journal-title":"Ann. Intern. Med."},{"issue":"7081","key":"10.1016\/j.thromres.2020.12.006_bb0195","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/nature04516","article-title":"Gout-associated uric acid crystals activate the NALP3 inflammasome","volume":"440","author":"Martinon","year":"2006","journal-title":"Nature."},{"issue":"10","key":"10.1016\/j.thromres.2020.12.006_bb0200","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1164\/rccm.200808-1274OC","article-title":"Uric acid is a danger signal activating NALP3 inflammasome in lung injury inflammation and fibrosis","volume":"179","author":"Gasse","year":"2009","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.thromres.2020.12.006_bb0205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2016\/8603164","article-title":"Role of uric acid metabolism-related inflammation in the pathogenesis of metabolic syndrome components such as atherosclerosis and nonalcoholic steatohepatitis","volume":"2016","author":"Kushiyama","year":"2016","journal-title":"Mediat. Inflamm."},{"issue":"11","key":"10.1016\/j.thromres.2020.12.006_bb0210","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1038\/ncprheum0338","article-title":"Interleukin 6: from bench to bedside","volume":"2","author":"Nishimoto","year":"2006","journal-title":"Nat Clin Pract Rheumatol."},{"issue":"9","key":"10.1016\/j.thromres.2020.12.006_bb0215","doi-asserted-by":"crossref","first-page":"2720","DOI":"10.1182\/blood.V98.9.2720","article-title":"Interleukin-6 stimulates thrombopoiesis through thrombopoietin: role in inflammatory thrombocytosis","volume":"98","author":"Kaser","year":"2001","journal-title":"Blood."},{"issue":"8","key":"10.1016\/j.thromres.2020.12.006_bb0220","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1182\/blood.V93.8.2525","article-title":"Soluble interleukin-6 (IL-6) receptor with IL-6 stimulates megakaryopoiesis from human CD34(+) cells through glycoprotein (gp)130 signaling","volume":"93","author":"Sui","year":"1999","journal-title":"Blood."},{"issue":"5","key":"10.1016\/j.thromres.2020.12.006_bb0225","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1172\/JCI108880","article-title":"Release of platelet constituents by monosodium urate crystals","volume":"60","author":"Ginsberg","year":"1977","journal-title":"J. Clin. Invest."},{"issue":"17","key":"10.1016\/j.thromres.2020.12.006_bb0230","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1056\/NEJMra0800885","article-title":"Uric acid and cardiovascular risk","volume":"359","author":"Feig","year":"2008","journal-title":"N. Engl. J. Med."},{"issue":"10","key":"10.1016\/j.thromres.2020.12.006_bb0235","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1093\/eurheartj\/ehi879","article-title":"Uric acid and inflammatory markers","volume":"27","author":"Ruggiero","year":"2006","journal-title":"Eur. Heart J."},{"issue":"16","key":"10.1016\/j.thromres.2020.12.006_bb0240","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJMra043430","article-title":"Inflammation, atherosclerosis, and coronary artery disease","volume":"352","author":"Hansson","year":"2005","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"10.1016\/j.thromres.2020.12.006_bb0245","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1084\/jem.20012044","article-title":"A critical role of platelet adhesion in the initiation of atherosclerotic lesion formation","volume":"196","author":"Massberg","year":"2002","journal-title":"J. Exp. Med."},{"issue":"11","key":"10.1016\/j.thromres.2020.12.006_bb0250","doi-asserted-by":"crossref","first-page":"3230","DOI":"10.1161\/01.ATV.17.11.3230","article-title":"In vivo formation of 8-Epi-prostaglandin F2 alpha is increased in hypercholesterolemia","volume":"17","author":"Davi","year":"1997","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"2","key":"10.1016\/j.thromres.2020.12.006_bb0255","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1161\/01.CIR.99.2.224","article-title":"In vivo formation of 8-iso-prostaglandin f2alpha and platelet activation in diabetes mellitus: effects of improved metabolic control and vitamin E supplementation","volume":"99","author":"Dav\u00ec","year":"1999","journal-title":"Circulation."},{"key":"10.1016\/j.thromres.2020.12.006_bb0260","doi-asserted-by":"crossref","unstructured":"Dav\u00ec G, Guagnano MT, Ciabattoni G, Basili S, Falco A, Marinopiccoli M, et al. Platelet activation in obese women: role of inflammation and oxidant stress. JAMA. 288(16):2008\u201314.","DOI":"10.1001\/jama.288.16.2008"},{"issue":"24","key":"10.1016\/j.thromres.2020.12.006_bb0265","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1056\/NEJMra071014","article-title":"Platelet activation and atherothrombosis","volume":"357","author":"Dav\u00ec","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.thromres.2020.12.006_bb0270","doi-asserted-by":"crossref","first-page":"9467562","DOI":"10.1155\/2019\/9467562","article-title":"Platelet and red blood cell counts, as well as the concentrations of uric acid, but not Homocysteinaemia or oxidative stress, contribute mostly to platelet reactivity in older adults","volume":"2019","author":"Karolczak","year":"2019","journal-title":"Oxid Med Cell Longev."},{"issue":"4","key":"10.1016\/j.thromres.2020.12.006_bb0275","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.numecd.2015.12.015","article-title":"Uric acid and high-residual platelet reactivity in patients treated with clopidogrel or ticagrelor","volume":"26","author":"Barbieri","year":"2016","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"issue":"1","key":"10.1016\/j.thromres.2020.12.006_bb0280","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1160\/TH09-02-0124","article-title":"The role of immature platelet fraction in acute coronary syndrome","volume":"103","author":"Gonzalez-Porras","year":"2010","journal-title":"Thromb. Haemost."},{"issue":"2","key":"10.1016\/j.thromres.2020.12.006_bb0285","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1007\/s11239-013-0932-x","article-title":"Propensity for young reticulated platelet recruitment into arterial thrombi","volume":"37","author":"McBane","year":"2014","journal-title":"J. Thromb. Thrombolysis"},{"issue":"8","key":"10.1016\/j.thromres.2020.12.006_bb0290","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1515\/cclm-2014-0165","article-title":"Reticulated platelets: analytical aspects and clinical utility","volume":"52","author":"Hoffmann","year":"2014","journal-title":"Clin. Chem. Lab. Med."},{"issue":"5","key":"10.1016\/j.thromres.2020.12.006_bb0295","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1055\/s-0035-1569405","article-title":"Effects of uric acid on the NO production of HUVECs and its restoration by urate lowering agents","volume":"66","author":"Mishima","year":"2016","journal-title":"Drug Res (Stuttg)."}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384820306538?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384820306538?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T17:44:50Z","timestamp":1758735890000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384820306538"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":59,"alternative-id":["S0049384820306538"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2020.12.006","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of uric acid on immature platelet fraction in patients undergoing percutaneous coronary intervention","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2020.12.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}